Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Activity Coefficient01:17

Factors Affecting Activity Coefficient

1.5K
The extended Debye-Hückel equation indicates that the activity coefficient of an ion in an aqueous solution at 25°C depends on three partially interdependent properties: the ionic strength of the solution, the charge of the ion, and the ion size. 
The activity coefficient value for an ion is close to one when the solution has almost zero ionic strength, i.e., when the solution shows close to ideal behavior. As the ionic strength of the solution increases from 0 to 0.1 mol/L, a...
1.5K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

254
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
254
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Factorial Design02:01

Factorial Design

13.7K
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
13.7K
Group Design02:01

Group Design

10.3K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.3K
Transcription Factors02:16

Transcription Factors

82.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Safety/Therapeutic Results of ALT-100 eNAMPT mAb Impact in the PUERTA Phase 2A ARDS Trial.

American journal of respiratory and critical care medicine·2026
Same author

Making infectious disease data local and as accessible as the weather forecast.

Nature medicine·2026
Same author

Infectious disease modeling for public health practice: projections, scenarios, and uncertainty in three phases of outbreak response.

American journal of epidemiology·2026
Same author

Likelihood ratio test for the disease progression model to measure saved time in Alzheimer's disease.

Statistical methods in medical research·2026
Same author

2024-2025 COVID-19 mRNA Vaccine Effectiveness against Severe Disease.

The Journal of infectious diseases·2026
Same author

Designing trials with multiple objectives with graphical approach for multiple scenarios.

Contemporary clinical trials communications·2025
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Jan 24, 2026

Computerized Adaptive Testing System of Functional Assessment of Stroke
05:21

Computerized Adaptive Testing System of Functional Assessment of Stroke

Published on: January 7, 2019

6.3K

Two-stage adaptive enrichment design for testing an active factor.

A Adam Ding1, Samuel S Wu2, Natalie E Dean2

  • 1Department of Mathematics, Northeastern University, Boston, Massachusetts, USA.

Journal of Biopharmaceutical Statistics
|May 29, 2019
PubMed
Summary
This summary is machine-generated.

This study introduces an adaptive enrichment method to efficiently test active factors by focusing on subpopulations with the strongest effects. This approach enhances statistical power for identifying treatment effects across various outcome types.

Keywords:
Active factoradaptive enrichment trialfisher’s combinationgene-treatment interaction

More Related Videos

Enrichment of Pachytene Spermatocytes and Spermatids from Mouse Testes Using Standard Laboratory Equipment
10:22

Enrichment of Pachytene Spermatocytes and Spermatids from Mouse Testes Using Standard Laboratory Equipment

Published on: September 17, 2019

12.1K
Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae
02:52

Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae

Published on: March 7, 2025

2.0K

Related Experiment Videos

Last Updated: Jan 24, 2026

Computerized Adaptive Testing System of Functional Assessment of Stroke
05:21

Computerized Adaptive Testing System of Functional Assessment of Stroke

Published on: January 7, 2019

6.3K
Enrichment of Pachytene Spermatocytes and Spermatids from Mouse Testes Using Standard Laboratory Equipment
10:22

Enrichment of Pachytene Spermatocytes and Spermatids from Mouse Testes Using Standard Laboratory Equipment

Published on: September 17, 2019

12.1K
Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae
02:52

Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae

Published on: March 7, 2025

2.0K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Inference

Background:

  • Identifying active factors requires methods sensitive to effects varying across subpopulations.
  • Traditional designs may lack efficiency when treatment effects are heterogeneous.
  • Adaptive strategies can improve power by focusing resources on promising subgroups.

Purpose of the Study:

  • To propose and evaluate an adaptive enrichment approach for testing active factors.
  • To enhance the efficiency and power of clinical trials with heterogeneous treatment effects.
  • To develop a robust statistical test applicable to different outcome types.

Main Methods:

  • A two-stage play-the-winner design is implemented.
  • Subjects in the second stage are selected from subpopulations with the highest observed effect in the first stage.
  • A weighted Fisher's combination of Hotelling's test (stage 1) and noncentral chi-square test (stage 2) is recommended.
  • The method is extended for binary and time-to-event outcomes.

Main Results:

  • The proposed adaptive enrichment approach increases statistical power for detecting active factors.
  • The two-stage design efficiently allocates resources to subpopulations with the largest effects.
  • The recommended weighted combination test provides a robust framework for analysis.
  • The extension to binary and time-to-event data broadens the applicability of the method.

Conclusions:

  • Adaptive enrichment strategies are effective for testing active factors in heterogeneous populations.
  • The proposed two-stage play-the-winner design offers an efficient and powerful approach.
  • The recommended statistical tests and extensions provide a versatile tool for clinical research.
  • This method can optimize resource allocation and improve the detection of treatment effects.